BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38382667)

  • 1. A growth factor-reduced culture system for colorectal cancer organoids.
    Tan R; Zhang Z; Ding P; Liu Y; Liu H; Lu M; Chen YG
    Cancer Lett; 2024 Apr; 588():216737. PubMed ID: 38382667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis.
    Wang R; Mao Y; Wang W; Zhou X; Wang W; Gao S; Li J; Wen L; Fu W; Tang F
    Genome Biol; 2022 Apr; 23(1):106. PubMed ID: 35484598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
    Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
    Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
    Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
    Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Proteome Profiles of Healthy and Tumor Human Colon Organoids Reveal Both Individual Diversity and Basic Features of Colorectal Cancer.
    Cristobal A; van den Toorn HWP; van de Wetering M; Clevers H; Heck AJR; Mohammed S
    Cell Rep; 2017 Jan; 18(1):263-274. PubMed ID: 28052255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB202190 Predicts BRAF-Activating Mutations in Primary Colorectal Cancer Organoids via Erk1-2 Modulation.
    Costa D; Venè R; Coco S; Longo L; Tosetti F; Scabini S; Mastracci L; Grillo F; Poggi A; Benelli R
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer.
    Toshimitsu K; Takano A; Fujii M; Togasaki K; Matano M; Takahashi S; Kanai T; Sato T
    Nat Chem Biol; 2022 Jun; 18(6):605-614. PubMed ID: 35273398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Organoids to Characterize Signaling Pathways in Cancer Initiation.
    Oatway C; Hirsch CL; Gregorieff A
    Methods Mol Biol; 2018; 1765():315-331. PubMed ID: 29589318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors.
    Szvicsek Z; Oszvald Á; Szabó L; Sándor GO; Kelemen A; Soós AÁ; Pálóczi K; Harsányi L; Tölgyes T; Dede K; Bursics A; Buzás EI; Zeöld A; Wiener Z
    Cell Mol Life Sci; 2019 Jun; 76(12):2463-2476. PubMed ID: 31028424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
    Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
    Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
    Fujii M; Shimokawa M; Date S; Takano A; Matano M; Nanki K; Ohta Y; Toshimitsu K; Nakazato Y; Kawasaki K; Uraoka T; Watanabe T; Kanai T; Sato T
    Cell Stem Cell; 2016 Jun; 18(6):827-838. PubMed ID: 27212702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
    Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
    Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug-induced phenotypic landscape of colorectal cancer organoids.
    Betge J; Rindtorff N; Sauer J; Rauscher B; Dingert C; Gaitantzi H; Herweck F; Srour-Mhanna K; Miersch T; Valentini E; Boonekamp KE; Hauber V; Gutting T; Frank L; Belle S; Gaiser T; Buchholz I; Jesenofsky R; Härtel N; Zhan T; Fischer B; Breitkopf-Heinlein K; Burgermeister E; Ebert MP; Boutros M
    Nat Commun; 2022 Jun; 13(1):3135. PubMed ID: 35668108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK-dependent colorectal cancer.
    Shimizu S; Kondo J; Onuma K; Coppo R; Ota K; Kamada M; Harada Y; Tanaka Y; Nakazawa MA; Tamada Y; Okuno Y; Kawada K; Obama K; Coffey RJ; Fujiwara Y; Inoue M
    Cancer Sci; 2023 Sep; 114(9):3636-3648. PubMed ID: 37357017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
    Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer.
    Wang Z; Zhou L; Wang Y; Peng Q; Li H; Zhang X; Su Z; Song J; Sun Q; Sayed S; Liu S; Lu D
    Theranostics; 2021; 11(9):4421-4435. PubMed ID: 33754069
    [No Abstract]   [Full Text] [Related]  

  • 19. A Bioinformatic Profile of Gene Expression of Colorectal Carcinoma Derived Organoids.
    A P; Xu X; Wang C; Ye L; Yang J
    Biomed Res Int; 2018; 2018():2594076. PubMed ID: 30363662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific metabolic response of patient-derived organoids to curcumin of colorectal cancer.
    Chen L; Dai Z; Ge C; Huang D; Zhou X; Pan K; Xu W; Fu J; Du JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jul; 1203():123260. PubMed ID: 35598460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.